N-nonyldeoxynojirimycin
Alternative Names: NN-DNJLatest Information Update: 23 Jan 2004
At a glance
- Originator Pharmacia Corporation; University of Oxford
- Class Antivirals; Small molecules
- Mechanism of Action Alpha-glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B; Hepatitis C
Most Recent Events
- 23 Jan 2004 Discontinued - Preclinical for Hepatitis B in United Kingdom (PO)
- 23 Jan 2004 Discontinued - Preclinical for Hepatitis B in USA (PO)
- 23 Jan 2004 Discontinued - Preclinical for Hepatitis C in United Kingdom (PO)